In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material.

Now, a little over 20 years later, Mammoth Biosciences is hoping to do the same thing for gene editing tools.

  Read more about [node:title]